{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:29Z","timestamp":1793500529943,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"Department of Internal Medicine, National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taiwan Clinical Trial Consortium of Infectious Diseases","award":["MOST 106-2321-B-002-031"],"award-info":[{"award-number":["MOST 106-2321-B-002-031"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cmi.2017.06.029","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T06:00:50Z","timestamp":1499493650000},"page":"159-165","source":"Crossref","is-referenced-by-count":71,"title":["Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-\u03b3 autoantibodies in patients with disseminated nontuberculous mycobacterial infection"],"prefix":"10.1016","volume":"24","author":[{"given":"U.-I.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-C.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-H.","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-Y.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-T.","family":"Jhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.06.029_bib1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","article-title":"Host susceptibility to non-tuberculous mycobacterial infections","volume":"15","author":"Wu","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2017.06.029_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00281-015-0552-y","article-title":"A\u00a0genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections","volume":"38","author":"Wu","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cmi.2017.06.029_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2017.06.029_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-032713-120222","article-title":"Anticytokine autoantibody-associated immunodeficiency","volume":"32","author":"Browne","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cmi.2017.06.029_bib5","doi-asserted-by":"crossref","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-gamma autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cmi.2017.06.029_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000347112","article-title":"Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: Sweet's syndrome and beyond","volume":"226","author":"Chan","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.cmi.2017.06.029_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","article-title":"Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2017.06.029_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s15010-010-0067-3","article-title":"Anti-interferon-gamma autoantibody and opportunistic infections: case series and review of the literature","volume":"39","author":"Kampitak","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2017.06.029_bib9","doi-asserted-by":"crossref","first-page":"e76371","DOI":"10.1371\/journal.pone.0076371","article-title":"Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand","volume":"8","author":"Wongkulab","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2017.06.029_bib10","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.06.029_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-13-24","article-title":"Fatal Mycobacterium colombiense\/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report","volume":"13","author":"Poulin","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2017.06.029_bib12","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection \u2013 United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cmi.2017.06.029_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00005792-198501000-00003","article-title":"Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature","volume":"64","author":"Horsburgh","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cmi.2017.06.029_bib14","first-page":"107","article-title":"Nontuberculous mycobacteria and associated diseases","volume":"119","author":"Wolinsky","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.cmi.2017.06.029_bib15","unstructured":"QuantiFERON-TB Gold. Available at: http:\/\/www.quantiferon.com\/products\/quantiferon-tb-gold\/. [Accessed 6 March 2017]."},{"key":"10.1016\/j.cmi.2017.06.029_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145983","article-title":"Immune alterations in patients with anti-interferon-gamma autoantibodies","volume":"11","author":"Chruewkamlow","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2017.06.029_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/cid\/cix372","article-title":"Repurposing QuantiFERON for detection of neutralizing IFN-gamma autoantibodies in patients with nontuberculous mycobacterial infections","volume":"65","author":"Suarez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.06.029_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10875-015-0161-5","article-title":"Late-onset disseminated Mycobacterium avium intracellulare Complex Infection (MAC), cerebral toxoplasmosis and Salmonella Sepsis in a German Caucasian patient with unusual anti-interferon-gamma IgG1 autoantibodies","volume":"35","author":"Hanitsch","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.cmi.2017.06.029_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jiac.2015.02.003","article-title":"Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-gamma neutralizing autoantibodies","volume":"21","author":"Hase","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.cmi.2017.06.029_bib20","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2017.06.029_bib21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2017.06.029_bib22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10875-014-0073-9","article-title":"The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-gamma autoantibodies","volume":"34","author":"O'Connell","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.cmi.2017.06.029_bib23","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J\u00a0Clin Invest"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17303567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17303567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T21:36:56Z","timestamp":1583876216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17303567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1198743X17303567"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.06.029","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}